DEPROIC SYRUP DIN 02238042
Status: Cancelled Post Market
Holder: TECHNILAB PHARMA INC.
Molecule: VALPROIC ACID (SODIUM VALPROATE)
Health Canada record
| Active ingredient(s) | VALPROIC ACID (SODIUM VALPROATE) 250 MG |
|---|---|
| Dosage form | Syrup |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AG01 VALPROIC ACID |
| Original market date | 02-Jun-1998 |
| Current status date | 28-Jul-2006 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VALPROIC ACID (SODIUM VALPROATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00443832 | DEPAKENE | BGP PHARMA ULC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02532441 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP PHARMA CORPORATION | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02549190 | ODAN-VALPROIC ACID | ODAN LABORATORIESLTD | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02236807 | PMS-VALPROIC ACID | PHARMASCIENCE INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02238069 | VALPROIC ACID ORAL SOLUTION | APOTEX INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Approved |
| 02238370 | APO-VALPROIC ACID ORAL SOLUTION | APOTEX INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Dormant |
| 00443840 | DEPAKENE | BGP PHARMA ULC | Capsule | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238817 | DOM-VALPROIC ACID | DOMINION PHARMACAL | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238368 | EPIJECT I.V. | ABBOTT LABORATORIES, LIMITED | Liquid | VALPROIC ACID (SODIUM VALPROATE) 500 MG | Cancelled Post Market |
| 02238210 | PHL-VALPROIC ACID | PHARMEL INC | Syrup | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02140063 | RATIO-VALPROIC 50MG/ML SYRUP | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Syrup | VALPROIC ACID (SODIUM VALPROATE) 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 3167 | 1998-05-27 | Abbreviated New Drug Submission (ANDS) |